Identifying key genes related to inflammasome in severe COVID-19 patients based on a joint model with random forest

Haiya Ou1, Yaohua Fan2,3, Xiaoxuan Guo2,3

  • 1Department of Gastroenterology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.

Insights

Five key inflammasome-related genes, including AXL, MKI67, CDKN3, BCL2, and PTGS2, are identified as potential biomarkers for severe COVID-19. These genes may aid in diagnosing severe coronavirus disease 2019 (COVID-19) cases.

Area of Science:

  • Genomics
  • Immunology
  • Computational Biology

Background:

  • Severe COVID-19 presents a high mortality rate, with poorly understood biomarkers and pathological mechanisms.
  • Identifying key genes and molecular pathways is crucial for understanding severe disease progression.

Approach:

  • Performed transcriptome meta-analysis to identify differentially expressed genes (DEGs) in severe COVID-19.
  • Utilized random forest and artificial neural network modeling to pinpoint key inflammasome-associated DEGs (IADEGs) and construct a diagnostic model.

Key Points:

  • Identified 192 DEGs and 40 IADEGs, with significant enrichment in immune response pathways.
  • Five key IADEGs (AXL, MKI67, CDKN3, BCL2, PTGS2) were identified using random forest analysis.
  • An artificial neural network model incorporating these five genes achieved high diagnostic efficacy (AUC 0.972 and 0.844).

Conclusions:

  • AXL, MKI67, CDKN3, BCL2, and PTGS2 are critical inflammasome-related genes in severe COVID-19.
  • These genes are linked to NLRP3 inflammasome activation and can serve as potential diagnostic markers for severe COVID-19.
  • The developed diagnostic model shows promise for identifying severe cases of coronavirus disease 2019.
Abstract

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Inflammation01:38

Inflammation

Overview
54.1K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
375
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.4K